Loading…
Peptron announced a delay in the completion of its new cGMP-grade sustained-release drug production facility investment from December 2026 to June 2027, and an increase in investment amount from 65 billion won to 89 billion won.
| Site | Largest | Latest |
|---|---|---|
| Daejeon, South Korea | $67.0M | 2025-12-03 |